BILTHOVEN, Netherlands, Dec. 22, 2020 /PRNewswire/ -- Intravacc, one of the world's leading translational research and development vaccine organisations, with an extensive track record in developing infectious diseases vaccines, today announced that it will become a Public Shareholding...
from PR Newswire: https://ift.tt/37JX44V
No comments:
Post a Comment